Effect of hydrogen sulfide on hepatic lipid accumulation in obese mice
10.3969/j.issn.1001-1978.2015.07.012
- VernacularTitle:硫化氢对肥胖小鼠肝脂质蓄积的影响
- Author:
Nairui ZHENG
;
Youjing ZHANG
;
Dongdong WU
;
Bin LIU
;
Ailing JI
;
Yanzhang LI
;
Chaoshen HUANGFU
- Publication Type:Journal Article
- Keywords:
hydrogen sulfide;
obesity;
fatty liver;
fatty acid synthase;
carnitine palmitoyltransferase-1;
mice
- From:
Chinese Pharmacological Bulletin
2015;(7):945-950,951
- CountryChina
- Language:Chinese
-
Abstract:
Aim To investigate the effect of hydrogen sulfide on hepatic lipid accumulation in obese mice. Methods C57 BL/6 J mice were randomly divided into control group, model group, and NaHS group. The mice of the control group were fed with normal diet. The mice of the model group and the NaHS group were fed with high-fat diet. From the thirteenth week, the mice of NaHS group were injected intraperitoneally with NaHS (H2S donor) in a dose of 50 μmol·kg-1 per day for 4 weeks and the mice of the model group were injected with the same volume of saline. All mice were sacrificed at the end of the 16th week. The tis-sues of liver were homogenized and centrifugated. The supernatants were used for the determination of triglyc-eride and cholesterol in liver. The morphology of liver was tested by H&E staining. Liver lipid accumulation was determined by oil red staining. Total RNA was ex-tracted from frozen tissue of liver. PCR was used to de-tect CPT-1 , FAS gene expression and ELISA method was used to detect CPT-1,FAS activity in mice liver. Results The body weight of the mice from NaHS group and model group was bigger than that of the mice from control group. Compared with the model group, the body weight of the mice from NaHS group was less;the content of triglyceride and cholesterol in liver was lower; the degree of liver tissue pathological changes and lipid accumulation were alleviated; CPT-1 expres-sion and activity were increased; FAS expression and activity were decreased. Conclusions These data in-dicate that hydrogen sulfide can reduce the lipid con-tent of liver tissue in obese mice and alleviate fatty liv-er. The mechanism may be associated with the in-creased expression of CPT-1 and the decreased expres-sion of FAS in liver.